ATE216585T1 - Antimikrobiell wirksame phospholipide mit antimikrobiellen stoffen - Google Patents

Antimikrobiell wirksame phospholipide mit antimikrobiellen stoffen

Info

Publication number
ATE216585T1
ATE216585T1 AT98956826T AT98956826T ATE216585T1 AT E216585 T1 ATE216585 T1 AT E216585T1 AT 98956826 T AT98956826 T AT 98956826T AT 98956826 T AT98956826 T AT 98956826T AT E216585 T1 ATE216585 T1 AT E216585T1
Authority
AT
Austria
Prior art keywords
antimicrobial substances
antimicrobially effective
phospholipids
effective phospholipids
antimicrobially
Prior art date
Application number
AT98956826T
Other languages
German (de)
English (en)
Inventor
Paul S Cohen
Karen Krogfelt
David C Laux
Maryjane Utley
Original Assignee
Statens Seruminstitut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Statens Seruminstitut filed Critical Statens Seruminstitut
Application granted granted Critical
Publication of ATE216585T1 publication Critical patent/ATE216585T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
AT98956826T 1997-11-20 1998-11-20 Antimikrobiell wirksame phospholipide mit antimikrobiellen stoffen ATE216585T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6690197P 1997-11-20 1997-11-20
PCT/DK1998/000512 WO1999026632A1 (en) 1997-11-20 1998-11-20 Phospholipids having antimicrobial activity with or without the presence of antimicrobials

Publications (1)

Publication Number Publication Date
ATE216585T1 true ATE216585T1 (de) 2002-05-15

Family

ID=22072448

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98956826T ATE216585T1 (de) 1997-11-20 1998-11-20 Antimikrobiell wirksame phospholipide mit antimikrobiellen stoffen

Country Status (11)

Country Link
US (1) US6165997A (enExample)
EP (1) EP1051180B1 (enExample)
JP (1) JP2001523723A (enExample)
AT (1) ATE216585T1 (enExample)
AU (1) AU747288B2 (enExample)
CA (1) CA2316340A1 (enExample)
DE (1) DE69805100T2 (enExample)
DK (1) DK1051180T3 (enExample)
ES (1) ES2177089T3 (enExample)
NZ (1) NZ505233A (enExample)
WO (1) WO1999026632A1 (enExample)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7048906B2 (en) 1995-05-17 2006-05-23 Cedars-Sinai Medical Center Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
US6861053B1 (en) 1999-08-11 2005-03-01 Cedars-Sinai Medical Center Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
AU1223099A (en) * 1997-11-24 1999-06-15 Zhongming Zeng Pharmaceutical formulation for stimulating the growth of gram-positive bacil li and increasing the acidity in vagina and the use thereof
GB9827865D0 (en) * 1998-12-18 1999-02-10 Woodcock Fiona Medicament
US6838480B1 (en) * 1999-05-28 2005-01-04 Marie Madeline Wharton Composition containing sucrafate and a topical anesthetic for humans and animals and method of use thereof
US6964949B2 (en) * 2000-05-24 2005-11-15 Shanghai Jiao Da Onlly Co., Ltd. Pharmaceutical compositions for promoting the growth of gram-positive bacilli and increasing the acidity in the vagina and the use thereof
US20040176323A1 (en) * 2001-04-25 2004-09-09 Song Dong Keun Pharmaceutical composition comprising lysophophatidic acid
CA2449002C (en) 2001-05-29 2011-08-16 Tap Pharmaceutical Products Inc. Enhancement of oral bioavailability of non-emulsified formulation of prodrug esters with lecithin
RU2259825C9 (ru) * 2001-06-18 2006-04-10 БиоДием Лимитед Вещества, проявляющие антимикробную, антигрибковую, антипротозойную активности
GB0201028D0 (en) * 2002-01-17 2002-03-06 Britannia Pharmaceuticals Ltd Prevention of infectious diseases
ITMI20021280A1 (it) * 2002-06-11 2003-12-11 Carlo Ghisalberti Metodo di trattamento anticellulite
US20050036972A1 (en) * 2003-03-10 2005-02-17 Hy-Gene Biomedical Corporation System for managing pathogens and irritants and monitoring usage of anti-bacterial formulations
CA2621066C (en) * 2005-08-29 2011-11-29 Sepsicure L.L.C. Method for treatment or prevention of conditions caused by gram-positive bacteria
EP1869981A1 (de) * 2006-06-21 2007-12-26 Staatliches Weinbauinstitut Freiburg Alkylphospholipide und Lyso-Phospholipide zur Bekämpfung von Pflanzenpathogenen
KR100870232B1 (ko) * 2006-12-07 2008-11-24 재단법인서울대학교산학협력재단 치아용 미백기능성 물질 전달시스템
WO2009057768A1 (ja) * 2007-11-02 2009-05-07 Nagase Chemtex Corporation 抗真菌剤及び抗菌剤
WO2009110938A2 (en) * 2007-12-10 2009-09-11 Novobiotic Pharmaceuticals Llc Novel macrocyclic polyene lactams
US9314524B2 (en) * 2007-12-31 2016-04-19 Calla Therapeutics Llc Topical formulations of Flucytosine
AU2010283998B2 (en) 2009-08-21 2015-01-29 Targeted Delivery Technologies Limited Vesicular formulations
US9693564B2 (en) * 2011-06-21 2017-07-04 Safehands Solutions, LLC Water based antimicrobial composition using benzalkonium chloride and cocamidopropyl PG-dimonium chloride phosphate
KR101315483B1 (ko) * 2011-06-23 2013-10-07 주식회사 아리바이오 항생제 및 라이소포스파티딜콜린을 포함하는 면역 증강 또는 세균성 감염 질환 치료용 조성물
GB201205642D0 (en) 2012-03-29 2012-05-16 Sequessome Technology Holdings Ltd Vesicular formulations
EP2805612A1 (en) 2013-05-22 2014-11-26 University of Graz Lysophospholipids against American Foulbrood
US11660344B2 (en) * 2013-11-17 2023-05-30 Medrx Co., Ltd. Transdermal colloidal solution agent
KR20160091315A (ko) * 2013-11-28 2016-08-02 큐피가부시키가이샤 다제내성 그램 양성균 항균제 및 외용제
PL3316856T3 (pl) 2015-06-30 2021-10-25 Sequessome Technology Holdings Limited Zmieszane formulacje
SG11202002600VA (en) 2017-09-21 2020-04-29 Scripps Research Inst Novel therapies for treating and preventing chronic rhinosinusitis
KR102641583B1 (ko) * 2018-10-23 2024-02-28 건국대학교 산학협력단 지도부딘을 포함하는 식물병 방제용 조성물
WO2023111173A1 (en) * 2021-12-16 2023-06-22 INSERM (Institut National de la Santé et de la Recherche Médicale) An ezh2 degrader or inhibitor for use in the treatment of resistant acute myeloid leukemia

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2185249A5 (enExample) * 1972-05-15 1973-12-28 Ibm
JPS5318581B2 (enExample) * 1974-03-12 1978-06-15
JPS5233139A (en) * 1975-09-08 1977-03-14 Masakane Katayama Automatic gas stop safety device with annunciator
JPS53118523A (en) * 1977-03-23 1978-10-17 Rikagaku Kenkyusho Fungicides for agriculture and horticulture, and composition for controlling agents against fruit pests during storage
EP0088046B1 (de) * 1982-02-17 1987-12-09 Ciba-Geigy Ag Lipide in wässriger Phase
US4588578A (en) * 1983-08-08 1986-05-13 The Liposome Company, Inc. Lipid vesicles prepared in a monophase
CA1237670A (en) * 1983-05-26 1988-06-07 Andrew S. Janoff Drug preparations of reduced toxicity
JPS6055564A (ja) * 1983-09-06 1985-03-30 Toshiba Corp エラ−訂正回路
US5135922A (en) * 1984-06-15 1992-08-04 Med-Tal, Inc. Prevention and treatment of microbial infection by phosphoglycerides
US5409704A (en) * 1985-06-26 1995-04-25 The Liposome Company, Inc. Liposomes comprising aminoglycoside phosphates and methods of production and use
JPS6216431A (ja) * 1985-07-15 1987-01-24 Nakanishi Michio 医薬組成物
US4923854A (en) * 1986-01-22 1990-05-08 The Liposome Company, Inc. Solubilization of hydrophobic materials using lysophospholipid
JPH0774132B2 (ja) * 1986-10-06 1995-08-09 旭電化工業株式会社 界面活性を有する静菌性組成物
NZ223660A (en) * 1987-03-05 1990-11-27 Liposome Co Inc Low toxicity drug-lipid complexes; methods of making them; and method of determining their toxicity
JP2877160B2 (ja) * 1987-07-29 1999-03-31 ザ リポソーム カンパニー，インコーポレイテッド 粒子のサイズによる分離方法
US5434182A (en) * 1987-12-31 1995-07-18 Isaacs; Charles E. Antibacterial fatty acid compositions
US5624958A (en) * 1987-12-31 1997-04-29 Isaacs; Charles E. Disinfecting contact lenses
US5466714A (en) * 1987-12-31 1995-11-14 Research Foundation For Mental Health Hygiene, Inc. Spermicidal and cytocidal fatty acid compositions
FR2636331B1 (fr) * 1988-09-12 1990-11-16 Bioeurope Procede de preparation d'acides lysophosphatidiques et de sels de ceux-ci
US4999199A (en) * 1988-11-10 1991-03-12 Board Of Regents, The University Of Texas System Pharmaceutical formulations: liposomes incorporating aromatic polyene antibiotics
JP2794072B2 (ja) * 1989-09-29 1998-09-03 株式会社ヤクルト本社 抗菌剤
ATE124262T1 (de) * 1990-12-21 1995-07-15 Microcarb Inc Verwendung von wirtszellphospholipiden zur hemmung bakterieller besiedlung.
IT1247165B (it) * 1991-03-15 1994-12-12 Fidia Spa Uso terapeutico della fosfatidilserina e derivati in patologie degenerative anche associate a disfunsioni immunitarie.
MX9206219A (es) * 1991-10-28 1994-01-31 Mona Industries Inc Composiciones antimicrobianas de fosfolipidos
US5648348A (en) * 1991-10-28 1997-07-15 Mona Industries, Inc. Phospholipid antimicrobial compositions
FR2683721B1 (fr) * 1991-11-15 1995-06-09 Inocosm Laboratoires Composition lipidique polaire permettant de vehiculer un agent actif et/ou de le faire penetrer dans une cellule cible.
US5292513A (en) * 1992-05-18 1994-03-08 Anthony G. Gristina Method for nonspecific cellular immune stimulation
JP2604940B2 (ja) * 1992-05-19 1997-04-30 株式会社リケン イオンプレーティング用蒸発材
JP2809573B2 (ja) * 1993-03-08 1998-10-08 科学技術振興事業団 新規リゾホスファチジルイノシトール及びその製造法
US5478819A (en) * 1993-06-23 1995-12-26 Simo Tarpila Phospholipid composition and use thereof
US5480877A (en) * 1993-11-02 1996-01-02 Wisconsin Alumni Research Foundation Use of lysophosphatidic acids to enhance fibronectin binding
JPH07147953A (ja) * 1993-11-29 1995-06-13 Yakult Honsha Co Ltd 抗菌剤及び抗菌剤の使用方法
AU3333695A (en) * 1994-05-31 1995-12-21 David P. Franklin Methods and products for the control of pathogenic bacteria
US6019989A (en) * 1994-06-21 2000-02-01 Institute For Advanced Skin Research Inc. Skin activator with glycosaminoglycan production-accelerating effect
FR2745184A1 (fr) * 1996-02-28 1997-08-29 Chanseau Sylvain Utilisation de la lecithine de soja pour la preparation d' un medicament contre le sida

Also Published As

Publication number Publication date
DK1051180T3 (da) 2002-08-19
JP2001523723A (ja) 2001-11-27
WO1999026632A8 (en) 1999-09-02
AU747288B2 (en) 2002-05-16
AU1333799A (en) 1999-06-15
EP1051180B1 (en) 2002-04-24
WO1999026632B1 (en) 1999-07-22
US6165997A (en) 2000-12-26
DE69805100D1 (de) 2002-05-29
ES2177089T3 (es) 2002-12-01
CA2316340A1 (en) 1999-06-03
DE69805100T2 (de) 2002-12-05
NZ505233A (en) 2002-07-26
WO1999026632A1 (en) 1999-06-03
EP1051180A1 (en) 2000-11-15

Similar Documents

Publication Publication Date Title
ATE216585T1 (de) Antimikrobiell wirksame phospholipide mit antimikrobiellen stoffen
ATE110578T1 (de) Von hydrogel angetriebene verabreichungsvorrichtung.
DK1037667T3 (da) Farmaceutiske hydrogelformuleringer, lægemiddelindgivelsesanordninger samt fremgangsmåder
EP1283050A3 (en) Improved therapeutic compositions comprising bactericidal/permeability-increasing (BPI) protein products
CO4290346A1 (es) Formas de dosificacion de liberacion controlada de azitromicina
BR0014818A (pt) Imidazo-3-il-aminas bicìclicas procedimento de preparação e medicamentos que contém como substância ativa pelo menos uma imidazo-3-il-amina bicìclica
DE60230635D1 (de) Körperpflegeprodukte mit elastomeren bereichen, welche einen antimikrobiellen wirkstoff enthalten
DE69938295D1 (de) Kleinlumiges biologisches transplantat mit therapeutischer verabreichungsvorrichtung
CY1107159T1 (el) Φαρμακευτικο και/ή καλλυντικο παρασκευασμα που περιεχει ενα οργανοσιλοξανιο και ενα φωσφολιπιδιο
PT806941E (pt) Composicoes anti-bacterianas liposomicas de rigidez baixa
DE69810189D1 (de) Zusammensetzungen mit kontrollierter Wirkstoffabgabe
FI961437A7 (fi) Vaikuttavan aineen luovuttava systeemi
AU2000255628A1 (en) Formulation comprising thymol useful in the treatment of drug resistant bacterial infections
PT1017392E (pt) Formulacao de medicamento com libertacao controlada do principio activo
ES2152912T1 (es) Metodo de mejorar las propiedades antimicrobianas de antibioticos antibacterianos.
BR9701887A (pt) Artigo absorvente higiênico com barreiras laterais contra o vazamento
DE60001266D1 (de) Betahistin-hältige formulierung mit kontrollierter wirkstofffreisetzung
ATE243419T1 (de) Wirkstoffkombinationen mit insektiziden und akariziden eigenschaften
FI963631A7 (fi) Insektisidisia tehoainekoostumuksia
PT793841E (pt) Dispositivo de controlo para um ecran com enderecamento activo
EP1044691A3 (en) Use of glycosaminoglycan lipid conjugates for inducing osteogenesis
CY1107038T1 (el) Μεθοδος θεραπειας βακτηριακων λοιμωξεων με χρηση της γεμιφλοξασινης ή ενος αλατος αυτης και ενος αντιβιοτικου β-λακταμης
ES2196769T3 (es) Uso topico de loperamide para el tratamiento de infecciones microbianas.
DE59510583D1 (de) Pharmazeutische zusammensetzung zur systemischen transdermalen verabreichung mit dem wirkstoff morphin-6-glucuronid
FI990977A7 (fi) Laite vaikuttavan aineen annosteluun ja annostelun tutkimukseen